Skip to main content

First FDA Treatments for Patients with Amyloidosis: Contributions From the Utah Amyloidosis Program

Jose N. Nativi-Nicolau MD

University of Utah Department of Internal Medicine Grand Rounds , "First FDA Treatments for Patients with Amyloidosis: Contributions From the Utah Amyloidosis Program" presented by Jose N. Nativi-Nicolau MD, MSCI, FACC, FHFSA, Associate Professor, Division of Cardiovascular Medicine, Department of Internal Medicine, University of Utah and Huntsman Cancer Institute

Download this video